ALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion

G. Soraru, G. Soraru, M. Clementi, M. Clementi, M. Forzan, M. Forzan, V. Orsetti, V. Orsetti, C. D'Ascenzo, C. D'Ascenzo, G. Querin, G. Querin, A. Palmieri, A. Palmieri, M. Ermani, M. Ermani, C. Angelini, C. Angelini, E. Pegoraro, E. Pegoraro
  • Neurology, June 2011, Wolters Kluwer Health
  • DOI: 10.1212/wnl.0b013e31821e557a

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1212/wnl.0b013e31821e557a

The following have contributed to this page: Prof Corrado Angelini